# Paracetamol and Patent Ductus Arteriosus (PDA)

> **NCT01291654** · PHASE2 · UNKNOWN · sponsor: **Shaare Zedek Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Patent Ductus Arteriosus

## Interventions

- **DRUG:** Paracetamol
- **DRUG:** NSAID
- **DRUG:** D5W

## Key facts

- **NCT ID:** NCT01291654
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2014-12
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2012-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01291654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01291654, "Paracetamol and Patent Ductus Arteriosus (PDA)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01291654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*